The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Novel Hypotheses in Parkinson's Disease, 2010Characterization of PP2A as a Novel Therapeutic Target and a Biomarker of PD
Objective/Rationale:
Protein phosphatase 2A (PP2A) is a key enzyme that dephosphorylates proteins. PP2A deficits may be critical causes of Parkinson’s disease (PD) - abnormalities in PP2A levels and... -
Understanding LRRK2 Biology, 2010Characterization of LRRK2 Cellular and Signaling Pathways
Promising Outcomes of Original Grant:
In the original funded grant, we propose to identify LRRK2 substrates using a chemical genetics approach. We have developed suitable methods and key reagents that... -
Alpha-Synuclein Therapeutics, 2010Neuroprotective efficacy of RAB3B in pre-clinical models of alpha-synucleinopathy
Objective/Rationale:
In Parkinson’s disease, the major motor symptoms are caused by the degeneration of dopamine producing neurons in the substantia nigra pars compacta. We have identified a... -
Alpha-Synuclein Therapeutics, 2010Testing of Davunetide for Intranasal Administration in Pre-clinical Models Over Expressing Alpha-synuclein
Objective/Rationale:
Davunetide is an investigational drug with the potential to treat Parkinson disease and is currently in a clinical trial for progressive supranuclear palsy, a rare progressive... -
Research Grant, 2010LRRK2 Effects on Neural Differentiation
Objective/Rationale:
Several lines of research suggest that leucine-rich repeat kinase 2 (LRRK2 or PARK8) levels or its activity can regulate the development of axons or dendrites, but some of the... -
MJFF Research Grant, 2010Determine the Structure of LRRK2 Protein
Objective/Rationale:
Mutations in the Leucine Rich Repeat Kinase 2 (LRRK2) gene are associated with Parkinson’s disease (PD). Although the biological function of LRRK2 is not known, inhibitors of...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.